Correction: Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial. | Clin Cancer Res;26(18): 5048, 2020 09 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL CLAP/WR-PAHO/WHO

Latin-American Center for Perinatology, Woman and Reproductive Health

Subject descriptor lookup Advanced Search

Correction: Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial.

Tang, Bixia; Chi, Zhihong; Chen, Yingbo; Liu, Xiufeng; Wu, Di; Chen, Jing; Song, Xin; Wang, Weifeng; Dong, Lihou; Song, Haifeng; Wu, Hai; Feng, Hui; Yao, Sheng; Qin, Shuikui; Zhang, Xiaoshi; Guo, Jun.

Clin Cancer Res ; 26(18): 5048, 2020 09 15.

Article in En | MEDLINE | ID: mdl-32934029

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2020 Type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2020 Type: Article